Loading Events

Opportunities in Women’s Health: A Fireside Chat Congressional Briefing with ORWH Director Clayton

  • This event has passed.

January 22 @ 12:00 pm - 12:30 pm EST

With the November 2023 announcement about the White House Initiative on Women’s Health Research, there is a renewed buzz around the opportunities to advance the health of women across the lifespan. During this exclusive conversation with Janine Clayton, MD, FARVO, Associate Director for Research on Women’s Health and Director of the National Institutes of Health (NIH) Office of Research on Women’s Health (ORWH), Dr. Clayton provides her insights into the current challenges and opportunities within women’s health. This event also tees up Women’s Health Research Day, which occurs annually on January 25. Women’s Health Research Day marks the implementation of the NIH Sex as a Biological Variable Policy, which outlines NIH’s expectation that sex as a biological variable will be factored into research designs, analyses, and reporting. During this event, the Friends of ORWH ask Dr. Clayton how we can better integrate SABV across the U.S. research enterprise.

This event is hosted by the Friends of the Office of Research on Women’s Health (FORWH).

*This event is widely attended and relevant to official duties.


January 22
12:00 pm - 12:30 pm EST
Event Categories:
, , , , ,




Janine Austin Clayton, MD

Director, NIH Office of Research on Women’s Health

Janine Austin Clayton, MD

Director, NIH Office of Research on Women’s Health

Dr. Clayton is Associate Director for Research on Women’s Health and Director of the Office of Research on Women’s Health (ORWH) at the National Institutes of Health (NIH). She is the architect of the NIH policy requiring scientists to consider sex as a biological variable across the research spectrum. This policy is part of NIH’s initiative to enhance reproducibility through rigor and transparency. As co-chair of the NIH Working Group on Women in Biomedical Careers with NIH Director Dr. Francis Collins, Dr. Clayton also leads NIH’s efforts to advance women in science careers.

Prior to joining the ORWH, Dr. Clayton was the Deputy Clinical Director of the National Eye Institute (NEI) for seven years. A board-certified ophthalmologist, Dr. Clayton’s research interests include autoimmune ocular diseases and the role of sex and gender in health and disease. She is the author of more than 120 scientific publications, journal articles, and book chapters.

Dr. Clayton, a native Washingtonian, received her undergraduate degree with honors from Johns Hopkins University and her medical degree from Howard University College of Medicine. She completed a residency in ophthalmology at the Medical College of Virginia. Dr. Clayton completed fellowship training in cornea and external disease at the Wilmer Eye Institute at Johns Hopkins Hospital and in uveitis and ocular immunology at NEI.

Dr. Clayton has received numerous awards, including the Senior Achievement Award from the Board of Trustees of the American Academy of Ophthalmology in 2008 and the European Uveitis Patient Interest Association Clinical Uveitis Research Award in 2010. She was selected as a 2010 Silver Fellow by the Association for Research in Vision and Ophthalmology. In 2015, she was awarded the American Medical Women’s Association Lila A. Wallis Women’s Health Award and the Wenger Award for Excellence in Public Service. Dr. Clayton was granted the Bernadine Healy Award for Visionary Leadership in Women’s Health in 2016. She was also selected as an honoree for the Woman’s Day Red Dress Awards and the American Medical Association’s Dr. Nathan Davis Awards for Outstanding Government Service in 2017.


Kathryn G. Schubert, MPP, CAE

President and CEO, Society for Women's Health Research

Kathryn G. Schubert, MPP, CAE

President and CEO, Society for Women's Health Research

Kathryn (Katie) Schubert joined the Society for Women’s Health Research (SWHR) as President and CEO in April 2020. Under Katie’s leadership SWHR developed a strategic plan focused on fulfilling the organization’s mission of promoting research on biological sex differences in disease and improving women’s health through science, policy, and education. She previously worked for the Society for Maternal-Fetal Medicine (SMFM), where she served as the organization’s chief advocacy officer, growing SMFM’s role nationally and building its reputation in women’s health.

Katie is a trusted leader and consensus builder among women’s health stakeholders, particularly in the policy arena. She has served in multiple Board roles for nonprofit organizations in the Washington, DC-area, including as Chair of the Board of the Maternal Mental Health Leadership Alliance and as advisor to the John E. Lewy Fund for Children’s Health. She is a past president of Women in Government Relations.

Prior to SMFM, Katie served as senior vice president at CRD Associates, where she advised clients — including nonprofit patient advocacy groups, medical professional organizations, and private companies — on government relations and public policy related to health and biomedical research issues, among others. She has also spent time working in key legislative roles on Capitol Hill. She received her BA from Mary Washington College and her Masters of Public Policy from George Washington University. Katie lives in Virginia with her husband, three children, and dog George.



Phone: (202) 496-5004